Role of CD73 and extracellular adenosine in disease : Presented by Maria P. Abbracchio.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

1. "Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach".Frontiers in immunology · 2025
   Review
2. An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
   Review
3. Extracellular ATP Regulates CD73 and ABCC6 Expression in HepG2 Cells.Frontiers in molecular biosciences · 2018
   Article
4. Does adenosine play a role in bone formation, resorption and repair?Purinergic signalling · 2012
   Article
5. Hypoxia signaling during intestinal ischemia and inflammation.Current opinion in critical care · 2012
   Review
6. An emerging role for adenosine and its receptors in bone homeostasis.Frontiers in endocrinology · 2012
   Article

Corrections and comments

• Erratum issued

Authors and funding

1 author at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.